Paraneoplastic disorders of the nervous system

Dalmau, 2005, Paraneoplastic neurologic disorders, 571 Rudnicki, 2000, Paraneoplastic syndromes of the spinal cord, nerve, and muscle, Muscle Nerve, 23, 1800, 10.1002/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X Graus, 2004, Recommended diagnostic criteria for paraneoplastic neurological syndromes, J Neurol, Neurosurg Psychiatry, 75, 1135, 10.1136/jnnp.2003.034447 Dalmau, 1999, Paraneoplastic neurologic syndromes: pathogenesis and physiopathology [In Process Citation., Brain Pathol, 9, 275, 10.1111/j.1750-3639.1999.tb00226.x Albert, 1998, Tumor-specific killer cells in paraneoplastic cerebellar degeneration, Nat Med, 11, 1321, 10.1038/3315 Bataller, 2003, Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment, Semin Neurol, 23, 215, 10.1055/s-2003-41134 Antoine, 2001, Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy, Ann Neurol, 49, 214, 10.1002/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W Vernino, 2000, Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies, N Engl J Med, 343, 847, 10.1056/NEJM200009213431204 Posner, 1995 Gultekin, 2000, Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients, Brain, 123, 1481, 10.1093/brain/123.7.1481 Mathew, 2006, Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis, Neurology Younes-Mhenni, 2004, FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes, Brain, 127, 2331, 10.1093/brain/awh247 Mathew, 2006, Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET, J Neurol Sci, 250, 153, 10.1016/j.jns.2006.06.029 Graus, 1997, Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival, J Clin Oncol, 15, 2866, 10.1200/JCO.1997.15.8.2866 Bataller, 2004, Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer, Neurology, 62, 778, 10.1212/01.WNL.0000113749.77217.01 Graus, 2002, P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer, Neurology, 59, 764, 10.1212/WNL.59.5.764 Dalmau, 1992, Anti-Hu- associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients, Medicine, 71, 59, 10.1097/00005792-199203000-00001 Sillevis, 2002, Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy, J Neurol, 249, 745, 10.1007/s00415-002-0706-4 Graus, 2001, Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients, Brain, 124, 1138, 10.1093/brain/124.6.1138 Dalmau, 2004, Clinical analysis of anti-Ma2-associated encephalitis, Brain, 127, 1831, 10.1093/brain/awh203 Alamowitch, 1997, Limbic encephalitis and small cell lung cancer. Clinical and immunological features, Brain, 120, 923, 10.1093/brain/120.6.923 Vernino, 2004, Immunomodulatory treatment trial for paraneoplastic neurological disorders, Neurooncol, 6, 55 Lawn, 2003, Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis, Mayo Clin Proc, 78, 1363, 10.4065/78.11.1363 Vincent, 2004, Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis, Brain, 127, 701, 10.1093/brain/awh077 Thieben, 2004, Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody, Neurology, 62, 1177, 10.1212/01.WNL.0000122648.19196.02 Iranzo, 2006, Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis, Ann Neurol, 59, 178, 10.1002/ana.20693 Ances, 2005, Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates, Brain, 128, 1764, 10.1093/brain/awh526 Buckley, 2001, Potassium channel antibodies in two patients with reversible limbic encephalitis, Ann Neurol, 50, 73, 10.1002/ana.1097 Pozo-Rosich, 2003, Voltage- gated potassium channel antibodies in limbic encephalitis, Ann, Neurol, 54, 530, 10.1002/ana.10713 Liguori, 2000, Acquired neuromyotonia after bone marrow transplantation, Neurology, 54, 1390, 10.1212/WNL.54.6.1390 Dalmau, 2007, Paraneoplastic anti-N- methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050 Bataller, 2006, Autoimmune Limbic Encephalitis in 39 Patients: Immunophenotypes and Outcomes, J Neurol Neurosurg Psychiatry, 10.1136/jnnp.2006.100644 Vitaliani, 2005, Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Ann Neurol, 58, 594, 10.1002/ana.20614 Koide, 2007, EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report, J Neurooncol, 81, 71, 10.1007/s11060-006-9200-7 Mason, 1997, Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome, Brain, 120, 1279, 10.1093/brain/120.8.1279 Shams'ili, 2003, Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients, Brain, 126, 1409, 10.1093/brain/awg133 Bernal, 2003, Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease, Neurology, 60, 230, 10.1212/01.WNL.0000041495.87539.98 Bataller, 2001, Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus, Brain, 124, 437, 10.1093/brain/124.2.437 Russo, 1997, Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group, Med Pediatr Oncol, 28, 284, 10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E Sutton, 2002, Paraneoplastic brainstem encephalitis and anti-Ri antibodies, J Neurol, 249, 1597, 10.1007/s00415-002-0863-5 Pranzatelli, 2005, Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome, Pediatrics, 115, e115, 10.1542/peds.2004-0845 Pranzatelli, 2005, Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone, J Pediatr, 147, 372, 10.1016/j.jpeds.2005.05.016 Tate, 2005, Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome, J Pediatr Oncol Nurs, 22, 8, 10.1177/1043454204272560 Brown, 1999, The stiff man and stiff man plus syndromes, J Neurol, 246, 648, 10.1007/s004150050425 De Camilli, 1993, The synaptic vesicle- associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer, J Exp Med, 178, 2219, 10.1084/jem.178.6.2219 Chalk, 1992, The distinctive clinical features of paraneoplastic sensory neuronopathy, Can J Neurol Sci, 19, 346, 10.1017/S0317167100041974 Camdessanche, 2002, Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients, Brain, 125, 166, 10.1093/brain/awf006 Oh, 2005, Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study, Clin Neurophysiol, 116, 28, 10.1016/j.clinph.2004.07.012 Oh, 1997, Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature, Muscle Nerve, 20, 1576, 10.1002/(SICI)1097-4598(199712)20:12<1576::AID-MUS13>3.0.CO;2-Z Wirtz, 2002, Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases, Clin Neurol Neurosurg, 104, 359, 10.1016/S0303-8467(02)00054-9 O'Neill, 1988, The Lambert-Eaton myasthenic syndrome. A review of 50 cases, Brain, 111, 577, 10.1093/brain/111.3.577 Wirtz, 2002, Difference in distribution of muscle weakness between myasthenia gravis and the Lambert- Eaton myasthenic syndrome, J Neurol Neurosurg Psychiatry, 73, 766, 10.1136/jnnp.73.6.766 Sanders, 2000, A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome [In Process Citation., Neurology, 54, 603, 10.1212/WNL.54.3.603 Newsom-Davis, 2003, Therapy in myasthenia gravis and Lambert- Eaton myasthenic syndrome, Semin Neurol, 23, 191, 10.1055/s-2003-41135 Sigurgeirsson, 1992, Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study, N Engl J Med, 326, 363, 10.1056/NEJM199202063260602 Maoz, 1998, High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis, Semin Arthritis Rheum, 27, 319, 10.1016/S0049-0172(98)80052-8 Garcia, 1998, [Report of 8 cases of dermatomyositis: does association of this entity and neoplasms exist? (see comments)., Rev Clin Esp, 198, 217 Maugars, 1996, Long-term prognosis of 69 patients with dermatomyositis or polymyositis, Clin Exp Rheumatol, 14, 263 Leow, 1997, Malignancy in adult dermatomyositis, Int J, Dermatol, 36, 904, 10.1046/j.1365-4362.1997.00190.x Davis, 1997, Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases, J Am Acad Dermatol, 37, 730, 10.1016/S0190-9622(97)70109-9 Mahe, 2003, A helpful clinical sign predictive of cancer in adult dermatomyositis: cutaneous necrosis, Arch Dermatol, 139, 539, 10.1001/archderm.139.4.539-a Hochberg, 1984, Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease, J Rheumatol, 11, 663 Lam, 1999, MR imaging in amyopathic dermatomyositis, Acta Radiol, 40, 69, 10.1080/02841859909174406 Dalakas, 1993, A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis [see comments., N Engl J Med, 329, 1993, 10.1056/NEJM199312303292704 Amato, 1997, Idiopathic inflammatory myopathies, Neurol Clin, 15, 615, 10.1016/S0733-8619(05)70337-6 Couriel, 2002, Chronic graft- versus-host disease manifesting as polymyositis: an uncommon presentation, Bone Marrow Transplant, 30, 543, 10.1038/sj.bmt.1703711 Arin, 2006, Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis, Clin Exp, Dermatol, 31, 141, 10.1111/j.1365-2230.2005.01934.x Levin, 1998, Paraneoplastic necrotizing myopathy: clinical and pathological features, Neurology, 50, 764, 10.1212/WNL.50.3.764 Anderlini, 1995, Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma, Cancer, 76, 678, 10.1002/1097-0142(19950815)76:4<678::AID-CNCR2820760422>3.0.CO;2-Q Bataller, 2004, Neuro-ophthalmology and paraneoplastic syndromes, Curr Opin Neurol, 17, 3, 10.1097/00019052-200402000-00003 Shiraga, 2002, Mechanism of CAR syndrome: anti- recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway, J, Neuroimmunol, 132, 72, 10.1016/S0165-5728(02)00314-4 Rosenfeld, 2006, Current therapies for neuromuscular manifestations of paraneoplastic syndromes, Curr Neurol, Neurosci Rep, 6, 77, 10.1007/s11910-996-0012-0 Vasconcelos, 2003, Stiff-person Syndrome, Curr, Treat Options Neurol, 5, 79, 10.1007/s11940-003-0024-x Vedeler, 2006, Management of paraneoplastic neurological syndromes: report of an EFNS Task Force, Eur J Neurol, 13, 682, 10.1111/j.1468-1331.2006.01266.x Dalmau, 2006, Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders, Hematol Oncol Clin North Am, 20, 1319, 10.1016/j.hoc.2006.09.011 Dalmau, 2006, Remote effects of cancer: Treatment of paraneoplastic neurologic disorders, 274